Research & Development
21 October 2026 - Swiss pharmaceutical company Novartis AG (SIX: NOVN; NYSE: NVS) on Wednesday said the European Commission has approved Cosentyx (secukinumab) for adults with polymyalgia rheumatica (...
21 October 2026 - Edwards Lifesciences Corporation (NYSE: EW), a structural heart innovation company, announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its...
21 October 2026 - GSK plc (LSE: GSK) (NYSE: GSK) has received US Food and Drug Administration approval for Hibsago (bepirovirsen), a first-in-class antisense oligonucleotide for treating chronic hepat...
20 October 2026 - Solventum Corporation (NYSE: SOLV), a US-based company involved in advanced wound healing, announced on Monday that the US Food and Drug Administration (FDA) has granted 510(k) clear...
19 October 2026 - Vivacta Biotechnology (Shanghai) Co Ltd (Vivacta Bio), a China-based company spun out of the in vivo CAR-T platform of Beijing Grit Biotherapeutics Co Ltd (Grit Bio), announced on Sa...
19 October 2026 - Pennsylvania-based global healthcare company Viatris Inc (Nasdaq: VTRS) announced on Friday that the US Food and Drug Administration (FDA) has approved RYZUMVI (phentolamine ophthalm...